EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

The chemo therapy of rodent malaria part 23 causal prophylaxis part 2 practical experience with plasmodium yoelii nigeriensis in drug screening



The chemo therapy of rodent malaria part 23 causal prophylaxis part 2 practical experience with plasmodium yoelii nigeriensis in drug screening



Annals of Tropical Medicine and Parasitology 69(3): 311-328



Data are presented on the causal prophylactic action of about 100 compounds of various types against P. yoelii nigeriensis N67 in mice. Examples are given to show how action against pre-erythrocytic schizonts may be differentiated from action on emerging erythrocytic stages. In a series of thirty-five 8-aminoquinolines, all but 10 showed definite causal prophylactic activity at tolerated doses. The data permit the compounds to be ranked in order of activity and many are more active in this test system than primaquine. Marked causal prophylactic activity is displayed by a variety of quinone structures, several of which show a significant residual action on blood stages. A high level of activity is found in dihydrofolate inhibitors within several chemical classes. Proguanil is more effective as a causal prophylactic than a blood schizontocide in the mouse as in man. Sulfonamides and sulfones are also effective in this system. Causal prophylactic action was detected in a number of experimental compounds including some antibiotics (such as tetracycline and clindamycin). The pyrocatechol RC 12 shows only slight activity at the maximum tolerated dose. Chloroquine, mepacrine, quinine, quinolinemethanols and phenanthrenemethanols are inactive as causal prophylactics. A rodent malaria-mouse model provides a relatively simple model for the screening of drugs for causal prophylaxis and the data so obtained are of relevance to the detection of causal prophylactics against human malaria.

(PDF 0-2 workdays service: $29.90)

Accession: 006614074

Download citation: RISBibTeXText



Related references

The chemotherapy of rodent malaria, XXIII Causal prophylaxis, part II: Practical experience with Plasmodium yoelii nigeriensis in drug screening. Annals of Tropical Medicine and Parasitology 69(3): 311-328, 1975

The chemo therapy of rodent malaria 34. causal prophylaxis 3. ultrastructural changes induced in exo erythrocytic schizonts of plasmodium yoelii yoelii by primaquine. Annals of Tropical Medicine and Parasitology 77(6): 555-568, 1983

The chemotherapy of rodent malaria XLI. Causal prophylaxis. Part V. Effect of mefloquine on exoerythrocytic schizogony in Plasmodium yoelii yoelii. Annals of Tropical Medicine and Parasitology 80(6): 577-580, 1986

The chemotherapy of rodent malaria, XXXIV. Causal prophylaxis Part III: Ultrastructural changes induced in exo-erythrocytic schizonts of Plasmodium yoelii yoelii by primaquine. Annals of Tropical Medicine and Parasitology 77(6): 555-568, 1983

The chemo therapy of rodent malaria part 22 the value of drug resistant strains of plasmodium berghei in screening for blood schizontocidal activity. Annals of Tropical Medicine & Parasitology 69(2): 155-172, 1975

The chemo therapy of rodent malaria part 14 the action of some sulfonamides alone or with folic reductase inhibitors against malaria vectors and parasites part 4 the response of normal and drug resistant strains of plasmodium berghei. Annals of Tropical Medicine & Parasitology 65(2): 123-129, 1971

Chemotherapy of rodent malaria 36. causal prophylaxis 4. activity of a new 8 aminoquinoline wr 225448 against exo erythrocytic schizonts of plasmodium yoelii yoelii. Annals of Tropical Medicine and Parasitology 78(5): 467-478, 1984

The chemo therapy of rodent malaria part 17 dynamics of drug resistance part 3 influence of drug combinations on the development of resistance to chloroquine in plasmodium berghei. Annals Of Tropical Medicine & Parasitology: 143-154, 1973

The chemo therapy of rodent malaria part 19 the action of a tetracycline derivative minocycline on drug resistant plasmodium berghei. Annals of Tropical Medicine & Parasitology 68(1): 41-46, 1974

Rodent malaria due to Plasmodium yoelii nigeriensis: a study of the Plasmodium pigment. Mediterranean Conference on Parasitology, 1: 17, 1977

The chemotherapy of rodent malaria XXXVI. Part IV. The activity of a new 8-aminoquinoline, WR 225,448 against exo-erythrocytic schizonts of Plasmodium yoelii yoelii. Annals of Tropical Medicine and Parasitology 78(5): 467-478, 1984

Changes in rodent-erythrocyte methemoglobin reductase system produced by two malaria parasites, viz. Plasmodium yoelii nigeriensis and Plasmodium berghei. Comparative Biochemistry and Physiology B, Biochemistry and Molecular Biology 129(4): 725-731, 2001

The chemo therapy of rodent malaria 32. the influence of p amino benzoic acid on the transmission of plasmodium yoelii and plasmodium berghei by anopheles stephensi. Annals of Tropical Medicine and Parasitology 74(3): 276-282, 1980

The chemo therapy of rodent malaria i host parasite relationships i the virulence of infection in relation to drug resistance and time elapsed since isolation of the wild strain mouse chloroquine anti parasit plasmodium berghei plasmodium berghei yoelii. Annals of Tropical Medicine & Parasitology 62(2): 238-245, 1968